Plasma homocysteine: A new risk factor for Alzheimer's disease?

Israel Medical Association Journal

Volumn 4, Issue 3, 2002, Pages 187-190

  Mizrahi, Eliyahu H ^a   Jacobsen, Donald W ^a   Friedland, Robert P ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AZARIBINE; CARBAMAZEPINE; CYANOCOBALAMIN; ESTROGEN; FOLIC ACID; FOLIC ACID ANTAGONIST; HOMOCYSTEINE; METHIONINE; METHOTREXATE; ORAL CONTRACEPTIVE AGENT; PHENYTOIN; THEOPHYLLINE;

ALCOHOLISM; ALZHEIMER DISEASE; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; COGNITIVE DEFECT; CORONARY ARTERY DISEASE; DEMETHYLATION; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; DRUG EFFECT; GENETIC ASSOCIATION; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; HYPOTHYROIDISM; KIDNEY DYSFUNCTION; KIDNEY METABOLISM; MALIGNANT NEOPLASTIC DISEASE; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL DEFICIENCY; PERNICIOUS ANEMIA; PSORIASIS; REVIEW; RISK FACTOR; STROKE; VASCULAR DISEASE;

ALZHEIMER DISEASE; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; RISK FACTORS; VITAMIN B 12;

EID: 0036282279     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Prevalence of Alzheimer disease in a community population of older persons. Higher than previously reported
2. The cerebral circulation and the mechanisms of Alzheimer's disease
3. Risk factors for vascular disease and dementia
4. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer disease in the Rotterdam study
5. Pathologic alterations of the cerebral microvasculature in Alzheimer disease and related dementing disorders
6. The association between midlife blood pressure levels and late life cognitive function: The Honolulu-Asia aging study
7. Homocysteine and cardiovascular disease
8. Homocysteine, Alzheimer's disease, and cognitive function
9. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with homocystinuria
10. Homocysteine and vitamins in cardiovascular disease
11. Sensitivity of serum methylmalonic acid and total homocysteine determinants for diagnosis of cobalamin and folate deficiencies
12. Total plasma homocysteine and cardiovascular risk profile - The Hordaland homocysteine study
13. Coffee consumption and plasma total homocysteine: The Hordaland homocysteine study
14. Hyperhomocysteinemia in chronic alcoholism: Correlation with folate, vitamin B-12, and vitamin B-6 status
15. Homocysteinemia in end stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes
16. Normalization of hyperhomocysteinemia with L-thyroxine in hypothyroidism
17. Total homocysteine in plasma or serum: Methods and clinical applications
18. Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease
19. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men
20. Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis
21. Nonfasting plasma total homocysteine level and mortality in middle aged and elderly men and women in Jerusalem
22. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphism, and B vitamins: The Atherosclerosis Risk in Communities (ARIC) study
23. The C677T in the methylenetetrahydrofolate reductase (MTHFR) gene and vascular dementia
24. Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people
25. Relations of vitamin B12, vitamin B6, folate, and homocysteine to cognitive performance in the Normative Aging Study
26. Total serum homocysteine in senile dementia of the Alzheimer's type
27. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease
28. Homocysteine and Alzheimer's disease
29. Identification of cognitive impairment in the elderly: Homocysteine is an early marker
30. Total homocysteine and cognitive decline in a community based sample of elderly subjects: The Rotterdam study
31. Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease
32. Mechanism of thrombosis in hyperhomocysteinemia
33. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor
34. Neurochemical characterization of excitoxin lesions in the cerebral cortex
35. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population
36. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: Sex differences and correlation with cobalamin and folate levels in normal subjects
37. Plasma homocysteine is a sensitive marker for tissue deficiency of both cobalamines and folates in a psychogeriatric population
38. B vitamins, homocysteine and neurocognitive function in the elderly
39. Vitamin B12 deficiency in dementia and cognitive impairment: The effects of treatment on neuropsychological function
40. Serum vitamin B12, C and folate concentration in the New Mexico elder healthy survey: Correlations with cognitive and affective functions